Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S B Howell

Showing results (221-230 of 260) with videos related to

Pageof 26
Sort By:
Gastroenterology|June 26, 1999
Mismatch repair proficiency and in vitro response to 5-fluorouracilJ M Carethers, D P Chauhan, D Fink, et al.
British Journal of Cancer|January 1, 1993
Regulation of initial vinblastine influx by P-glycoproteinD R Shalinsky, A P Jekunen, J E Alcaraz, et al.
Toxicology and Applied Pharmacology|May 1, 1994
Role of metallothionein in carcinogenesisM G Cherian, S B Howell, N Imura, et al.
The Journal of Clinical Investigation|November 1, 1990
Epidermal growth factor regulates the in vitro sensitivity of human ovarian carcinoma cells to cisplatinR D Christen, D K Hom, D C Porter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1985
High-dose cisplatin with sodium thiosulfate protectionC E Pfeifle, S B Howell, R D Felthouse, et al.
Annals of Internal Medicine|December 1, 1982
Intraperitoneal cisplatin with systemic thiosulfate protectionS B Howell, C L Pfeifle, W E Wung, et al.
American Journal of Surgery|November 1, 1994
A targeted supradose cisplatin chemoradiation protocol for advanced head and neck cancerK T Robbins, D Vicario, S Seagren, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
all-trans retinoic acid enhances cisplatin-induced apoptosis in human ovarian adenocarcinoma and in squamous head and neck cancer cellsS Aebi, R Kröning, B Cenni, et al.
Cancer|July 15, 1994
A phase I trial of intraperitoneal carboplatin and etoposide with granulocyte macrophage colony stimulating factor support in patients with intraabdominal malignanciesE F McClay, P D Braly, S Kirmani, et al.
Gynecologic Oncology|September 1, 1994
A comparison of intravenous versus intraperitoneal chemotherapy for the initial treatment of ovarian cancerS Kirmani, P S Braly, E F McClay, et al.
Pageof 26

Showing results (221-230 of 260) with videos related to

Sort By:
Pageof 26
Gastroenterology|June 26, 1999
Mismatch repair proficiency and in vitro response to 5-fluorouracilJ M Carethers, D P Chauhan, D Fink, et al.
British Journal of Cancer|January 1, 1993
Regulation of initial vinblastine influx by P-glycoproteinD R Shalinsky, A P Jekunen, J E Alcaraz, et al.
Toxicology and Applied Pharmacology|May 1, 1994
Role of metallothionein in carcinogenesisM G Cherian, S B Howell, N Imura, et al.
The Journal of Clinical Investigation|November 1, 1990
Epidermal growth factor regulates the in vitro sensitivity of human ovarian carcinoma cells to cisplatinR D Christen, D K Hom, D C Porter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1985
High-dose cisplatin with sodium thiosulfate protectionC E Pfeifle, S B Howell, R D Felthouse, et al.
Annals of Internal Medicine|December 1, 1982
Intraperitoneal cisplatin with systemic thiosulfate protectionS B Howell, C L Pfeifle, W E Wung, et al.
American Journal of Surgery|November 1, 1994
A targeted supradose cisplatin chemoradiation protocol for advanced head and neck cancerK T Robbins, D Vicario, S Seagren, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
all-trans retinoic acid enhances cisplatin-induced apoptosis in human ovarian adenocarcinoma and in squamous head and neck cancer cellsS Aebi, R Kröning, B Cenni, et al.
Cancer|July 15, 1994
A phase I trial of intraperitoneal carboplatin and etoposide with granulocyte macrophage colony stimulating factor support in patients with intraabdominal malignanciesE F McClay, P D Braly, S Kirmani, et al.
Gynecologic Oncology|September 1, 1994
A comparison of intravenous versus intraperitoneal chemotherapy for the initial treatment of ovarian cancerS Kirmani, P S Braly, E F McClay, et al.
Pageof 26